Dr. Randal S. Weber on Anti-EGFR Agents Showing Efficacy in Squamous Cell Carcinoma
February 24th 2016Weber says overactivity of these EGFR receptors may cause SCC tumors to become more aggressive. He adds that in a recent, small-scale study, effectively blocking the EGFR receptor in the tumor with anti-EGFR therapy proved to be successful.